Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension.
about
Somatic mutations in solid tumors: a spectrum at the service of diagnostic armamentarium or an indecipherable puzzle? The morphological eyes looking for BRAF and somatic molecular detections on cyto-histological samplesAmerican Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision MakingGerman Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.Conventional US, elastography, and contrast enhanced US features of papillary thyroid microcarcinoma predict central compartment lymph node metastases.The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer.The Frequency and Clinical Implications of the BRAF(V600E) Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades.The role of epigenetic alterations in papillary thyroid carcinogenesis.Poorly differentiated thyroid carcinoma: an incubating entity.Aggressive variants of follicular cell derived thyroid carcinoma; the so called 'real thyroid carcinomas'.Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management.External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society.Clinicopathological relevance of antithyroglobulin antibodies in low-risk papillary thyroid cancer.Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis.Crucial parameters in thyroid carcinoma reporting - challenges, controversies and clinical implications.Morphological features that can predict BRAFV600E -mutated carcinoma in paediatric thyroid cytology.Clinical implication of cancer adhesion in papillary thyroid carcinoma: clinicopathologic characteristics and prognosis analyzed with degree of extrathyroidal extension.Morphological parameters able to predict BRAF(V600E) -mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience.Identification of a novel HRAS variant and its association with papillary thyroid carcinoma.Extent of Extrathyroidal Extension as a Significant Predictor of Nodal Metastasis and Extranodal Extension in Patients with Papillary Thyroid Carcinoma.Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology.BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation.Notch1 receptor as a marker of lymph node metastases in papillary thyroid cancer.Radioactive iodine treatment for node negative papillary thyroid cancer with capsular invasion only: Results of a large retrospective study.Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct.The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.
P2860
Q28070226-50542E07-85FD-4131-B427-7A41496E58C5Q28084710-FFFBB4C5-7166-487A-9EEA-D9ED26E8330BQ30317867-2A594BD6-9C79-4F0F-982E-B9BA3462E309Q30420724-AFFED20A-DAEA-460C-B9BB-CD0C40DAFDB6Q34119390-BA2CB6B5-B947-4DF3-A788-476E1DB3EBCFQ34839781-A95C93DC-618F-4D76-8DE5-EB6795EF3A11Q35099482-4A861A36-3CD9-41EA-B059-2C53649347F2Q36050222-3AD31F07-D853-448B-B525-0897FA4F83E6Q38102673-F554FABA-DFF5-417C-9E65-05B45B530DDFQ38677660-3EA8907F-7BE4-4F4F-AA5A-20EAC7561EB5Q38682900-D265CC1A-4460-4A79-B08E-E623638286B4Q39106373-808B8E79-D231-4587-850B-4F282A713EBEQ41019891-4A6D1B21-053A-4CEF-9B0F-92E0CF0EC379Q48283721-8375F86C-5C38-4F83-9E2B-21EBDBBF0AACQ50891662-6795363F-8A88-4FA6-9432-B9582300D4C7Q51069620-33D183A5-1A79-4BE3-A44E-36EEAC3D188BQ51118023-365A0CE7-E8A3-4948-A093-6B36B38E0B39Q52647717-A7BD0CE4-8A4A-4669-9FBB-41DFAAC93ED5Q53024366-97672028-DD96-44A6-94EC-0C05788DD57AQ53097586-C8502EFF-5137-40DA-9332-0FA436A02D9DQ53265606-715F13CC-7B46-43ED-A45A-9F90685E4237Q53396811-88ADD641-E341-4585-8A46-54C277875524Q54514969-20FCE9DF-E8EF-46CC-997B-4AD6A1DEA607Q54529725-74F391AF-5449-4FDB-B213-C13EA80F9EB0Q54564143-20842567-8F6E-4340-8F11-F8011F315C4F
P2860
Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular, morphologic, and ou ...... ree of extrathyroid extension.
@en
Molecular, morphologic, and ou ...... ree of extrathyroid extension.
@nl
type
label
Molecular, morphologic, and ou ...... ree of extrathyroid extension.
@en
Molecular, morphologic, and ou ...... ree of extrathyroid extension.
@nl
prefLabel
Molecular, morphologic, and ou ...... ree of extrathyroid extension.
@en
Molecular, morphologic, and ou ...... ree of extrathyroid extension.
@nl
P2093
P2860
P356
P1433
P1476
Molecular, morphologic, and ou ...... ree of extrathyroid extension.
@en
P2093
Ashok Shaha
James Fagin
Jeffrey Knauf
Julio Ricarte-Filho
Michael Rivera
Robert Michael Tuttle
Ronald Ghossein
P2860
P304
P356
10.1089/THY.2010.0174
P50
P577
2010-10-01T00:00:00Z